Article
Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer.
Oncotarget - 11 Jul 2017
Qu Lili, Li Liangliang, Zheng Xiaofei, Fu Hanjiang, Tang Chuanhao, Qin Haifeng, Li Xiaoyan, Wang Hong, Li Jianjie, Wang Weixia, Yang Shaoxing, Wang Lin, Zhao Guanhua, Lv Panpan, Lei Yangyang, Zhang Min, Gao Hongjun, Song Santai, Liu Xiaoqing
Abstract excerpt
We aimed to identify a panel of circulating plasma microRNAs that can predict EGFR mutation status and monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with non-small cell lung cancer. Microarrays were performed for the preliminary screening of dysregulated microRNAs in 9 EGFR mutation-positive patients versus healthy controls. MiR-107 was upregulated and miR-195 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.